SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Library

| Daily Briefing

Weekly review: The 149 best hospitals, according to Leapfrog


How likely omicron is to cause reinfection, whether omicron is milder than other variants, and more.

How likely is the omicron variant to cause reinfection? Here's what a new study found. (Monday, Dec. 6)

A new study from South Africa suggests the omicron variant is much more likely than other variants to reinfect those who previously had Covid-19. Here's what experts say the finding could mean for both natural and vaccine-induced immunity against the coronavirus.

Is omicron actually milder than other variants? Here's what we know so far. (Tuesday, Dec. 7)

Early data from South Africa suggests that, while the omicron variant spreads remarkably quickly, it may cause relatively mild Covid-19 symptoms. But public health experts warn omicron may appear mild only because—so far—it's spreading in populations that already have widespread immunity from prior coronavirus waves.

Do vaccines protect against omicron? What early evidence shows. (Wednesday, Dec. 8)

Three new laboratory studies show troubling signs that two doses of the Pfizer-BioNTech coronavirus vaccine may not fully protect against the omicron variant. But the research also suggests that three doses may provide much better protection.

The 149 best hospitals, according to Leapfrog (Thursday, Dec. 9)

The Leapfrog Group on Monday released its 2021 Top Hospitals list, recognizing 149 hospitals for excellence in hospital quality, patient safety, and efficiency—and 115 hospitals on the list are Advisory Board members.

Omicron evades many vaccine antibodies. (But that doesn't mean vaccines won't work.) (Friday, Dec. 10)

Early data suggests the omicron variant may be better able to evade vaccine antibodies than other variants. But several infectious disease experts caution that these findings don't provide a complete picture of omicron's ability to escape vaccine-induced immunity, and that vaccinated people will likely remain protected against severe outcomes.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.